Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling

Antitubulin drugs are commonly used for the treatment of numerous cancers. However, either the intrinsic or acquired resistances of patients to these drugs result in the failure of the treatment and high mortality of cancers. Therefore, identifying genes or signalling pathways involved in antitubuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yulei, Yang, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673135/
https://www.ncbi.nlm.nih.gov/pubmed/26183396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673135/
https://www.ncbi.nlm.nih.gov/pubmed/26183396

Ejemplares similares